Loading…
Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?
Abstract Objective The objective was to explore whether 3-T magnetic resonance imaging (MRI) can identify low-risk ductal carcinoma in situ (DCIS). Methods Dynamic contrast-enhanced and diffusion-weighted (DWI) MRI features of 36 DCIS lesions [8 low risk, Van Nuys Pathologic Classification (VNPC) 1;...
Saved in:
Published in: | Clinical imaging 2016-01, Vol.40 (1), p.125-129 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract Objective The objective was to explore whether 3-T magnetic resonance imaging (MRI) can identify low-risk ductal carcinoma in situ (DCIS). Methods Dynamic contrast-enhanced and diffusion-weighted (DWI) MRI features of 36 DCIS lesions [8 low risk, Van Nuys Pathologic Classification (VNPC) 1; 28 high risk, VNPC 2/3] were reviewed. An MRI model that best identified low-risk DCIS was determined using multivariate logistic regression. Results Low-risk DCIS exhibited different DWI properties [i.e., higher contrast-to-noise ratio ( P = .02) and lower normalized apparent diffusion coefficients ( P = .04)] than high-risk DCIS. A model combining these DWI features provided best performance (area under receiver operating characteristic curve = 0.86). Conclusions DWI may help identify DCIS lesions requiring less therapy. |
---|---|
ISSN: | 0899-7071 1873-4499 |
DOI: | 10.1016/j.clinimag.2015.07.026 |